Mrna 1273 - Pharma

Please wait while the information is being loaded...

Relevant Publications

The association between acute transverse myelitis and COVID-19 vaccination in Korea: Self-controlled case series study.

Issue Release: 2025

Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting.

Issue Release: 2024

Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study.

Issue Release: 2024

Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Diplopia Caused by an Alternative Coronavirus Disease 2019 Vaccine.

Issue Release: 2024

Nodal T-Follicular Helper Cell Lymphoma, Angioimmunoblastic-Type, Diagnosed in a Patient with Psoriasis Following COVID-19 Vaccination under Adalimumab Treatment: A Causal Association?

Issue Release: 2024

SARS-CoV-2 mRNA vaccine-related myocarditis and pericarditis: An analysis of the Japanese Adverse Drug Event Report database.

Issue Release: 2024

Efficacy, Effectiveness, and Safety of COVID-19 Vaccine Compared to Placebo in Preventing COVID-19 Infection among 12-17 Years Old: A Systematic Review.

Issue Release: 2024

Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England.

Issue Release: 2024

SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity.

Issue Release: 2024

COVID-19 Vaccine-Associated Uveitis in Patients With a History of Uveitis.

Issue Release: 2024

Autoimmune encephalitis mediated by postvaccination and infection of SARS-CoV-2 in a patient with a narcolepsy type 1.

Issue Release: 2024

Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac and ChAdOx1-S Vaccines for SARS-CoV-2.

Issue Release: 2024

mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network.

Issue Release: 2024

Effectiveness of mRNA booster doses in preventing infections and hospitalizations due to SARS-CoV-2 and its dominant variant over time in Valencian healthcare workers, Spain.

Issue Release: 2024

Follow-Up and Comparative Assessment of SARS-CoV-2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA-1273 Heterologous Booster Vaccination.

Issue Release: 2024

Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population.

Issue Release: 2024

COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2.

Issue Release: 2024

Coagulation and inflammatory response after intramuscular or intradermal mRNA-1273 SARS-CoV-2 vaccine: secondary analysis of a randomized trial.

Issue Release: 2024

Association between COVID-19 vaccination and stroke: a nationwide case-control study in Qatar.

Issue Release: 2024

Immunostimulatory/Immunodynamic model of mRNA-1273 to guide pediatric vaccine dose selection.

Issue Release: 2024

What are the Challenges in Implementing Collaborative Care Models?

Who are Pharmacists?

What Challenges Exist in Patient Education?

What Are the Therapeutic Approaches to Mitigate Cellular Stress?

How are New Drugs Discovered?

Why Are Clinical Trials Important?

How Can Cellular Stress Be Measured?

What is Generic Competition?

What Roles Do Pharmacists Play in Pharma?

What are the Challenges Faced by Generic Manufacturers?

Mrna 1273 - Pharma

Relevant Publications

Partnered Content Networks

Relevant Topics